T.N.23 ROSIGLITAZONE INHIBITS HEPATOCELLULAR CANCER CELL GROWTH AND DOWN-REGULATES RUVBL-1: EVIDENCES OF A PPARgamma-INDEPENDENT MECHANISM OF CELL GROWTH INHIBITION

Authors :: V. Foresta
Stefano Milani
F. Buccoliero
L. Cioni
Calogero Surrenti
Tommaso Mello
Simone Polvani
Mirko Tarocchi
Elisabetta Ceni
B. Ottanelli
Andrea Galli
Source :: Digestive and Liver Disease. 42:S23
Publication Year :: 2010
Publisher :: Elsevier BV, 2010.

Subjects :: Hepatocellular cancer
Hepatology
Cell growth
Mechanism (biology)
business.industry
Gastroenterology
Cancer research
medicine
Growth factor receptor inhibitor
Rosiglitazone
business
medicine.drug

Tools